← Back to Search

Counseling for Depression and Suicide Risk

N/A

Recruiting

Led By Sydney S Ey, Ph.D.

Research Sponsored by Oregon Health and Science University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* OHSU medical residents, fellows, and full-time School of Medicine faculty

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time of intake to participants' end of treatment or 6 months since last seen

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether an anonymous online screening for stress, depression, substance use, and suicidal thoughts will help medical trainees and faculty who are in distress. It is expected that the screening will make them more likely to come for counseling and that their suicide risk factors will be lower after they receive treatment.

Who is the study for?

This trial is for OHSU medical residents, fellows, and full-time School of Medicine faculty who may be experiencing stress, depression, substance use issues, or suicidal thoughts. The goal is to see if anonymous online screening can encourage them to seek in-person counseling.

What is being tested?

The study tests an online interactive screening tool designed to identify distress signs like depression and suicidal thoughts among medical professionals. It aims to determine if this approach increases their likelihood of pursuing further counseling.

What are the potential side effects?

Since the intervention involves counseling without medication or invasive procedures, no direct physical side effects are expected. However, discussing sensitive topics might cause temporary emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time of intake to participants' end of treatment or 6 months since last seen

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time of intake to participants' end of treatment or 6 months since last seen

This trial's timeline: 3 weeks for screening, Varies for treatment, and time of intake to participants' end of treatment or 6 months since last seen for reporting.